Feline Cancer Map Reveals Genetic Overlaps with Human Cancers

- The research, published in the journal *Science*, analyzed 493 tumor and healthy tissue samples from pet cats across five countries, examining 13 different types of cancer. - One of the most frequently mutated genes identified was *TP53*, which was altered in 33% of the feline tumors studied—a rate that is nearly identical to the 34% found in human cancers. - In feline mammary tumors, which are often aggressive, over half of the cancers had mutations in the *FBXW7* gene; this same gene mutation is associated with a poorer prognosis in human breast cancer. - The concept of using data from naturally occurring cancers in pets to inform human medicine is known as "comparative oncology," a field that leverages the shared environments and genetic similarities between species. Humans and cats share about 90% of their genes. - This type of large-scale genetic analysis is typical of a career in bioinformatics or computational biology, which involves using programming skills (like Python and R) and statistics to analyze massive biological datasets and uncover patterns. Professionals in this tech-focused track often pursue a Master's or Ph.D. to work in academic research or for biotech and pharmaceutical companies. - The insights from this genetic map could lead to new treatments that would be tested in clinical research, a more patient-facing career path. A clinical researcher or a veterinarian-scientist (D.V.M./Ph.D.) would design and manage trials to see if a drug targeting a gene like *FBXW7* is effective and safe in cats, and potentially later, in humans. - Researchers have already tested this link in the lab, finding that feline mammary cancer cells with *FBXW7* mutations were more sensitive to a class of human chemotherapy drugs called vinca alkaloids.